Indications and uses
relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew. to prevent symptoms, swallow 1 tablet with a glass of water at any time from 15 to 60 minutes before eating food or drinking beverages that cause heartburn do not use more than 2 tablets in 24 hours children under 12 years: ask a doctor
read the directions and warnings before use keep the carton. It contains important information. store at 20° to 25°C (68° to 77°F) protect from moisture
Drug Facts
Famotidine USP 10 mg
Acid reducer
Allergy alert: Do not use if you are allergic to famotidine or other acid reducers
taking a prescription drug. Acid reducers may interact with certain prescription drugs.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away
carnauba wax, corn starch, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, red iron oxide, sodium starch glycolate, talc and titanium dioxide.
call 1-855-274-4122
Tips for Managing Heartburn
JUST ONE TABLET prevents and relieves heartburn due to acid indigestion brought on by eating and drinking certain foods and beverages.
Do not use if carton is open or if printed foil seal under bottle cap is open or torn.
Manufactured by:
Aurobindo Pharma Limited
Unit-VII (SEZ), Mahabubnagar (Dt)-509302, India
.
For BluePoint Laboratories
Rev: 02/2023
Aurobindo Pharma Limited. NDC: 68001-494-04
Famotidine Tablets USP 10mg 30s Label
Aurobindo Pharma Limited. NDC: 68001-494-04
Famotidine Tablets USP 10mg 30s Carton
| Class | Version | Type | Effective |
|---|---|---|---|
| FAMOTIDINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae | Product name | 7 | 20260317 |
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| cf645750-2e70-f6e1-c05a-a52847def5dd | Product name | 9 | 20250312 |
| 4fdc761c-585e-054b-8ebe-86130a26e4c1 | Product name | 2 | 20221205 |
| fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68001-494-04 | Famotidine | 1 in 1 CARTON | TABLET | 1 | 3 | |
| 68001-494-04 | Famotidine | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 68001-494-06 | Famotidine | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 68001-494-06 | Famotidine | 1 in 1 CARTON | TABLET | 1 | 3 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68001-494-04 | EA - Each | 68001-494 | ca1a15a1-0258-4b20-af07-64d6f96ac448 | 1 | 2021-06-02 |
| 68001-494-06 | EA - Each | 68001-494 | 210ac992-220c-455c-925d-295442c0a2fa | 1 | 2021-08-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68001-494 | 68001-494-04, 68001-494-06 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206531-001 | FAMOTIDINE | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | ||
| A206531-002 | FAMOTIDINE | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A206531-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2016-04-26 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A206531-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2016-04-26 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Famotidine | FAMOTIDINE | BluePoint Laboratories | befd8d44-c6f7-eca2-e053-2995a90a714b | 2023-03-23 | Warnings | 68001-494-06 68001-494-04 68001-494 68001049404 68001049406 f79353ac-03fd-35b1-e053-6394a90a86ae befd8d44-c6f7-eca2-e053-2995a90a714b |
Adverse event summaries are temporarily unavailable. Other product information remains available.